Lewis Sanders
Sanders Capital
Sanders Capital Portfolio 13F
Lewis Sanders Holdings Activity
- Portfolio value:
- $8.61B≈ (+$217M≈)
- Previous value:
- $8.40B≈
- # of changes:
- 50
- New positions:
- 1
- Reported for:
- 31 Mar 2014 (Q1)
- Latest filing date:
- 07 Sep 2022
Sanders Capital has disclosed a total of 50 changes to the portfolio in the (2014 Q1) SEC report(s): increased the number of shares of 11, bought 1 totally new, decreased the number of shares of 36 and completely sold out 2 position(s).
What stocks did Lewis Sanders buy in 2014 Q1?
During 2014 Q1 Lewis Sanders has bought 12 securities out of which top 5 purchases (by % change to portfolio) were (C) Citigroup Inc (added shares +13.97%), (AAPL) Apple Inc (added shares +56.90%), (DHI) DR Horton Inc (added shares +152.22%), (BBBYQ) Bed Bath & Beyond Inc (added shares +442.07%) and (RYL) RYLAND GROUP INC/THE (added shares +113.02%).
In the 2014 Q1 report(s) the following changes have been made to the top investments: (MSFT) Microsoft Corp (reduced shares -0.80%), (C) Citigroup Inc (added shares +13.97%), (INTC) Intel Corp (reduced shares -0.50%), (BAC) Bank of America Corp (reduced shares -0.85%) and (JPM) JPMorgan Chase & Co (reduced shares -0.83%).
50 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Meritage Corp
|
new
|
$41.88
|
+77.85%($74.48)
|
0.82%
|
2014 Q1
|
≈ 0.25 years
|
||||
|
|
Bed Bath & Beyond Inc
|
+442.07%
|
$68.80
|
|
1.32%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
|
|
DR Horton Inc
|
+152.22%
|
$21.65
|
+591.87%($149.79)
|
2.15%
|
2013 Q4
|
≈ 0.50 years
|
||||
|
|
RYLAND GROUP INC/THE
|
+113.02%
|
$39.93
|
|
1.04%
|
2013 Q4
|
≈ 0.50 years
|
||||
|
|
Stanley Black & Decker Inc
|
+84.71%
|
$81.24
|
+25.76%($102.17)
|
0.61%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
|
|
Apple Inc
|
+56.90%
|
$19.17
|
+1,516.08%($309.79)
|
3.66%
|
2013 Q3
|
≈ 0.75 years
|
||||
|
|
Sanofi ADR
|
+14.50%
|
$52.28
|
-18.21%($42.76)
|
0.05%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
|
|
Citigroup Inc
|
+13.97%
|
$47.60
|
+187.73%($136.96)
|
5.11%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
|
|
Cigna Corp
|
+13.19%
|
$83.73
|
+229.33%($275.75)
|
0.67%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
|
|
Vanguard FTSE All-World ex-US Index Fund ETF Shares
|
+11.16%
|
$50.31
|
+68.02%($84.54)
|
0.26%
|
2013 Q2 or earlier
|
≈ 1.00+ year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.